ACUTUS MEDICAL, INC.

Analyst Reco. Acutus Medical, Inc.

Equities

AFIB

US0051111096

Market Closed - Nasdaq Other stock markets 02:00:00 02/05/2024 am IST			5-day change	1st Jan Change
0.153 ^USD	+2.00%		-8.27%	-24.22%

04/04	North American Morning Briefing : Focus Turns to -2-	DJ
01/04	Acutus Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BTIG Adjusts Acutus Medical's Price Target to $1.50 From $2, Reiterates Buy Rating	24/22/24	MT
BTIG Upgrades Acutus Medical to Buy from Neutral, Sets $2 Price Target	27/22/27	MT
Goldman Sachs Adjusts Acutus Medical Price Target to $1 From $5, Maintains Neutral Rating	14/22/14	MT
BTIG Downgrades Acutus Medical to Neutral From Buy	20/22/20	MT
Canaccord Genuity Downgrades Acutus Medical to Hold from Buy, Adjusts Price Target to $3 from $10	14/22/14	MT
Canaccord Genuity Adjusts Acutus Medical's Price Target to $10 From $18, Maintains Buy Rating	12/21/12	MT
JPMorgan Downgrades Acutus Medical to Underweight From Neutral	12/21/12	MT
ACUTUS MEDICAL : Goldman Sachs Starts Actus Medical at Neutral with $10 Price Target	22/21/22	MT
ACUTUS MEDICAL : Canaccord Genuity Upgrades Acutus Medical to Buy From Hold; Price Target is $18	15/21/15	MT
ACUTUS MEDICAL : William Blair Downgrades Acutus Medical to Market Perform From Outperform	19/21/19	MT
ACUTUS MEDICAL : JPMorgan Downgrades Acutus Medical to Neutral From Overweight, Adjusts Price Target to $19 From $39	19/21/19	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer